Related Experiment Video
Updated: May 8, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Influenza virus M2e with additional cysteine residues shows enhanced immunogenicity and protection against lethal
Kazuyoshi Kaminaka1, Jun-Ichi Matsuda, Chikateru Nozaki
1Applied Research Department, Kikuchi Research Center, The Chemo-sero-therapeutic Research Institute, Kikuchi-city, Kumamoto, Japan.
Abstract:
The amino acid sequence of the extracellular domain of matrix protein 2 (M2e) is conserved among all subtypes of influenza A viruses. Therefore, the M2e peptide can be considered as a target antigen for the development of a universal influenza vaccine. We evaluated the effects of adding cysteine residues to a peptide of amino acids 2-24 of M2e. Mice immunized with some of these peptides containing one, two, three, four, or five extra cysteines displayed enhanced antibody titers to M2e. In addition, immunization with a peptide containing three extra cysteines, along with an aluminum adjuvant, protected mice more effectively against a lethal influenza virus challenge than the original M2e peptide. These results indicated that an M2e peptide containing additional cysteine residues could be a universal influenza vaccine candidate even without the addition of strong adjuvants.
Insights
Developing a universal influenza vaccine is possible using the influenza A virus matrix protein 2 ectodomain (M2e) peptide. Adding cysteine residues to the M2e peptide enhanced antibody responses and protection in mice.
Area of Science:
- Immunology
- Virology
- Vaccine Development
Background:
- The extracellular domain of matrix protein 2 (M2e) is conserved across all influenza A virus subtypes.
- M2e represents a potential target antigen for a universal influenza vaccine.
Purpose of the Study:
- To investigate the impact of incorporating cysteine residues into an M2e peptide.
- To evaluate the immunogenicity and protective efficacy of modified M2e peptides as universal influenza vaccine candidates.
Main Methods:
- Synthesized M2e peptides with varying numbers of additional cysteine residues.
- Immunized mice with these modified peptides, with and without aluminum adjuvant.
- Assessed antibody titers against M2e and measured protection against lethal influenza virus challenge.
Main Results:
- Peptides with one to five additional cysteines induced enhanced M2e-specific antibody titers in mice.
- A peptide with three additional cysteines, combined with an aluminum adjuvant, provided superior protection against lethal influenza challenge compared to the original M2e peptide.
- These findings suggest M2e peptides with extra cysteines may elicit protective immunity without strong adjuvants.
Conclusions:
- M2e peptides with additional cysteine residues are promising candidates for universal influenza vaccines.
- The inclusion of cysteine residues enhances the immunogenic potential of M2e peptides.
- Further development of M2e-based vaccines could offer broad protection against influenza A viruses.
More Related Videos
10:39Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
12:18Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
Published on: November 6, 2013
Related Concept Videos
Leaky Scanning
Influenza